? ? This Core Support Center Grant (P30) application requests continued support for an analytic and synthetic chemistry laboratory and administrative shared core infrastructure. The participating, currently funded, constituent projects continue research programs with human laboratory and treatment clinic studies of the clinical pharmacology of abused drugs, pharmacotherapies and other treatment strategies to treat drug abuse and addictions. Drugs of interest to participating projects include tobacco and nicotine, cocaine, methamphetamine and other phenethylamines, ephedra alkaloids, caffeine, gamma-hydroxybutyrate (GHB), salvinorin, adenosine, neurosteroids, and opiates. Analytical methods have been developed and validated in the core laboratory to support studies with these drugs. Other assays and labeled compounds will be made available as needed. Disciplines represented by the participating projects and investigators include psychiatry, clinical psychology, neurology, general internal medicine, cardiology and clinical pharmacology, psychopharmacology, toxicology, genetics, pediatrics, pharmacy, organic, medicinal and analytical chemistry, and statistics.
Our aims are: (1) To provide a state-of-the-art, well equipped and staffed, analytical and synthetic chemistry resource for the participating projects of drug abuse researchers at UCSF and at other institutions. (2) To provide administrative resources for preparation of manuscripts, IRB documents, and for data processing and reporting, grants management, and other administrative services needed to serve participating projects. (3) To provide statistical consulting services regarding study design and data analysis to participating projects. The long-term objective is to provide a facility with adequate administrative and laboratory resources with stability of support in order to be responsive to the needs of individual funded constituent scientific projects as they change and evolve over time. This facility is a cost-effective shared laboratory resource that enhances and extends research of investigators currently funded by NIH or other federal or nonfederal sources to further our understanding of human psychoactive drug use, abuse and addiction, its health consequences and its management. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA012393-06
Application #
6902152
Study Section
Special Emphasis Panel (ZDA1-RXL-E (02))
Program Officer
Chiang, Nora
Project Start
1999-09-01
Project End
2010-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
6
Fiscal Year
2005
Total Cost
$659,893
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Pulvers, Kim; Emami, Ashley S; Nollen, Nicole L et al. (2018) Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes. Nicotine Tob Res 20:206-214
Panzer, Ariane R; Lynch, Susan V; Langelier, Chaz et al. (2018) Lung Microbiota Is Related to Smoking Status and to Development of Acute Respiratory Distress Syndrome in Critically Ill Trauma Patients. Am J Respir Crit Care Med 197:621-631
Benowitz, Neal L; Flanagan, Christie A; Thomas, Timothy K et al. (2018) Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users. Int J Circumpolar Health 77:1528125
Vogel, Erin A; Ramo, Danielle E; Rubinstein, Mark L (2018) Prevalence and correlates of adolescents' e-cigarette use frequency and dependence. Drug Alcohol Depend 188:109-112
Rubinstein, Mark L; Delucchi, Kevin; Benowitz, Neal L et al. (2018) Adolescent Exposure to Toxic Volatile Organic Chemicals From E-Cigarettes. Pediatrics 141:
Benowitz, Neal L; Nardone, Natalie; Jain, Shonul et al. (2018) Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents. Cancer Epidemiol Biomarkers Prev 27:254-261
St Helen, Gideon; Shahid, Marian; Chu, Sherman et al. (2018) Impact of e-liquid flavors on e-cigarette vaping behavior. Drug Alcohol Depend 189:42-48
Nabavizadeh, Pooneh; Liu, Jiangtao; Havel, Christopher M et al. (2018) Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control 27:s13-s19
St Helen, Gideon; Jacob Iii, Peyton; Nardone, Natalie et al. (2018) IQOS: examination of Philip Morris International's claim of reduced exposure. Tob Control 27:s30-s36
Hang, Bo; Snijders, Antoine M; Huang, Yurong et al. (2017) Early exposure to thirdhand cigarette smoke affects body mass and the development of immunity in mice. Sci Rep 7:41915

Showing the most recent 10 out of 187 publications